Group i mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Xu, Zhao Hui ^a   Yang, Qi ^a   Feng, Bin ^a   Liu, Shui Bing ^a   Zhang, Nan ^a   Xing, Jiang Hao ^a   Li, Xiao Qiang ^a   Wu, Yu Mei ^a   Gao, Guo Dong ^b   Zhao, Ming Gao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dopamine; Group I mGluRs; Long term potentiation prefrontal cortex

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPA RECEPTOR; DLAP 3; DOPAMINE 1 RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR KINASE 2; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DRUG POTENTIATION; EMBRYO; FRAGILE X SYNDROME; HYPERACTIVITY; LEARNING; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL; NONHUMAN; PROTEIN CONTENT; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ALANINE; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; MICE, KNOCKOUT; NEURONS; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE;

MUS;

EID: 84861427428     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-24     Document Type: Article

References (65)

1. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, et al. Cell 1991 65 905 914 10.1016/0092-8674(91)90397-H 1710175
2. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G, Cell 1994 77 33 39 10.1016/0092-8674(94) 90232-1 8156595
3. Translational suppression by trinucleotide repeat expansion at FMR1. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST, Science 1995 268 731 734 10.1126/science.7732383 7732383
4. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA, Nelson DL, Nat Genet 1994 8 88 94 10.1038/ng0994-88 7987398
5. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL, Science 1991 252 1097 1102 10.1126/science.252. 5009.1097 17797906
6. Of mice and the fragile X syndrome. Kooy RF, Trends Genet 2003 19 148 154 10.1016/S0168-9525(03)00017-9 12615009
7. New insights into fragile X syndrome: from molecules to neurobehaviors. Jin P, Warren ST, Trends Biochem Sci 2003 28 152 158 10.1016/S0968-0004(03) 00033-1 12633995
8. The fragile X syndrome: from molecular genetics to neurobiology. Willemsen R, Oostra BA, Bassell GJ, Dictenberg J, Ment Retard Dev Disabil Res Rev 2004 10 60 67 10.1002/mrdd.20010 14994290
9. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Huber KM, Gallagher SM, Warren ST, Bear MF, Proc Natl Acad Sci U S A 2002 99 7746 7750 10.1073/pnas.122205699 12032354
10. The mGluR theory of fragile X mental retardation. Bear MF, Huber KM, Warren ST, Trends Neurosci 2004 27 370 377 10.1016/j.tins.2004.04.009 15219735
11. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M, J Neurosci 2005 25 7385 7392 10.1523/JNEUROSCI.1520-05.2005 16093389
12. Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. Rex CS, Lauterborn JC, Lin CY, Kramar EA, Rogers GA, Gall CM, Lynch G, J Neurophysiol 2006 96 677 685 10.1152/jn.00336.2006 16707719
13. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. Lauterborn JC, Rex CS, Kramar E, Chen LY, Pandyarajan V, Lynch G, Gall CM, J Neurosci 2007 27 10685 10694 10.1523/JNEUROSCI.2624-07.2007 17913902
14. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Wilson BM, Cox CL, Proc Natl Acad Sci U S A 2007 104 2454 2459 10.1073/pnas.0610875104 17287348
15. Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. Deng PY, Sojka D, Klyachko VA, J Neurosci 2011 31 10971 10982 10.1523/JNEUROSCI.2021-11.2011 21795546
16. A synaptic model of memory: long-term potentiation in the hippocampus. Bliss TV, Collingridge GL, Nature 1993 361 31 39 10.1038/361031a0 8421494
17. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Malenka RC, Nicoll RA, Trends Neurosci 1993 16 521 527 10.1016/0166-2236(93)90197-T 7509523
18. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF, Proc Natl Acad Sci U S A 2011 108 2587 2592 10.1073/pnas.1013855108 21262808
19. The presence of background dopamine signal converts long-term synaptic depression to potentiation in rat prefrontal cortex. Matsuda Y, Marzo A, Otani S, J Neurosci 2006 26 4803 4810 10.1523/JNEUROSCI.5312-05.2006 16672653
20. Dopamine receptor excess and mouse madness. Snyder SH, Neuron 2006 49 484 485 10.1016/j.neuron.2006.02.002 16476659
21. Dopamine and working memory mechanisms in prefrontal cortex. Surmeier DJ, J Physiol 2007 581 885 10.1113/jphysiol.2007.134502 17495037
22. Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Huang YY, Simpson E, Kellendonk C, Kandel ER, Proc Natl Acad Sci U S A 2004 101 3236 3241 10.1073/pnas.0308280101 14981263
23. A half-century of neurotransmitter research: impact on neurology and psychiatry. Carlsson A, Nobel lecture. Biosci Rep 2001 21 691 710
24. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. West AR, Grace AA, J Neurosci 2002 22 294 304 11756513
25. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Williams GV, Goldman-Rakic PS, Nature 1995 376 572 575 10.1038/376572a0 7637804
26. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. Sun X, Zhao Y, Wolf ME, J Neurosci 2005 25 7342 7351 10.1523/JNEUROSCI.4603-04.2005 16093384
27. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. Tseng KY, O'Donnell P, J Neurosci 2004 24 5131 5139 10.1523/JNEUROSCI.1021-04.2004 15175382
28. Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex. Chen G, Greengard P, Yan Z, Proc Natl Acad Sci U S A 2004 101 2596 2600 10.1073/pnas.0308618100 14983054
29. Selenium level in the environment and the population of Zhoukoudian area, Beijing, China. Li N, Gao Z, Luo D, Tang X, Chen D, Hu Y, Sci Total Environ 2007 381 105 111 10.1016/j.scitotenv.2007.03.027 17509665
30. Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. Trantham-Davidson H, Neely LC, Lavin A, Seamans JK, J Neurosci 2004 24 10652 10659 10.1523/JNEUROSCI.3179-04. 2004 15564581
31. FMRP acts as a key messenger for dopamine modulation in the forebrain. Wang H, Wu LJ, Kim SS, Lee FJ, Gong B, Toyoda H, Ren M, Shang YZ, Xu H, Liu F, et al. Neuron 2008 59 634 647 10.1016/j.neuron.2008.06.027 18760699
32. An area specialized for spatial working memory in human frontal cortex. Courtney SM, Petit L, Maisog JM, Ungerleider LG, Haxby JV, Science 1998 279 1347 1351 10.1126/science.279.5355.1347 9478894
33. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC, Science 1997 277 968 971 10.1126/science.277.5328.968 9252330
34. Long-term potentiation and evidence for novel synaptic association in CA1 stratum oriens of rat hippocampus. Otani S, Connor JA, Levy WB, Learn Mem 1995 2 101 106 10.1101/lm.2.2.101 10467569
35. Studies on the role of metabotropic glutamate receptors in long-term potentiation: some methodological considerations. Bortolotto ZA, Bashir ZI, Davies CH, Taira T, Kaila K, Collingridge GL, J Neurosci Methods 1995 59 19 24 10.1016/0165-0270(94)00189-N 7475246
36. Desensitization of G protein-coupled receptors and neuronal functions. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG, Annu Rev Neurosci 2004 27 107 144 10.1146/annurev.neuro.27.070203.144206 15217328
37. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. Otmakhova NA, Lisman JE, J Neurosci 1996 16 7478 7486 8922403
38. Differential cAMP signaling at hippocampal output synapses. Wozny C, Maier N, Fidzinski P, Breustedt J, Behr J, Schmitz D, J Neurosci 2008 28 14358 14362 10.1523/JNEUROSCI.4973-08.2008 19118168
39. Postsynaptic mechanisms are essential for forskolin-induced potentiation of synaptic transmission. Sokolova IV, Lester HA, Davidson N, J Neurophysiol 2006 95 2570 2579 16394076
40. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nicoll RA, Malenka RC, Nature 1995 377 115 118 10.1038/377115a0 7675078
41. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. Schulz PE, Cook EP, Johnston D, J Neurosci 1994 14 5325 5337 7916043
42. Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. Creager R, Dunwiddie T, Lynch G, J Physiol 1980 299 409 424 7381775
43. Excitatory amino acid receptors and synaptic plasticity. Collingridge GL, Singer W, Trends Pharmacol Sci 1990 11 290 296 10.1016/0165-6147(90)90011-V 2167544
44. Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Lu YM, Roder JC, Davidow J, Salter MW, Science 1998 279 1363 1367 10.1126/science.279.5355.1363 9478899
45. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Zhao MG, Toyoda H, Lee YS, Wu LJ, Ko SW, Zhang XH, Jia Y, Shum F, Xu H, Li BM, et al. Neuron 2005 47 859 872 10.1016/j.neuron.2005. 08.014 16157280
46. NMDA receptor-dependent long-term depression in the anterior cingulate cortex. Toyoda H, Zhao MG, Zhuo M, Rev Neurosci 2006 17 403 413 17139841
47. Enhanced synaptic long-term potentiation in the anterior cingulate cortex of adult wild mice as compared with that in laboratory mice. Zhao MG, Toyoda H, Wang YK, Zhuo M, Mol Brain 2009 2 11 10.1186/1756-6606-2-11 19445686
48. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Lee FJ, Xue S, Pei L, Vukusic B, Chery N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F, Cell 2002 111 219 230 10.1016/S0092-8674(02)00962-5 12408866
49. Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory. Nai Q, Li S, Wang SH, Liu J, Lee FJ, Frankland PW, Liu F, Biol Psychiatry 2010 67 246 254 10.1016/j.biopsych.2009.08.011 19846062
50. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. Gao C, Sun X, Wolf ME, J Neurochem 2006 98 1664 1677 10.1111/j.1471-4159.2006.03999.x 16800848
51. Dopaminergic stimulation of local protein synthesis enhances surface expression of GluR1 and synaptic transmission in hippocampal neurons. Smith WB, Starck SR, Roberts RW, Schuman EM, Neuron 2005 45 765 779 10.1016/j.neuron.2005. 01.015 15748851
52. Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. Larson J, Jessen RE, Kim D, Fine AK, du Hoffmann J, J Neurosci 2005 25 9460 9469 10.1523/JNEUROSCI.2638-05.2005 16221856
53. Cyclic AMP metabolism in fragile X syndrome. Berry-Kravis E, Huttenlocher PR, Ann Neurol 1992 31 22 26 10.1002/ana.410310105 1371909
54. Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. Nicola SM, Malenka RC, J Neurosci 1997 17 5697 5710 9221769
55. The molecular biology of memory storage: a dialogue between genes and synapses. Kandel ER, Science 2001 294 1030 1038 10.1126/science.1067020 11691980
56. Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. Gonzalez-Islas C, Hablitz JJ, J Neurosci 2003 23 867 875 12574415
57. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Seamans JK, Yang CR, Prog Neurobiol 2004 74 1 58 10.1016/j.pneurobio.2004.05.006 15381316
58. How to build a central synapse: clues from cell culture. Craig AM, Graf ER, Linhoff MW, Trends Neurosci 2006 29 8 20 10.1016/j.tins.2005.11.002 16337695
59. Synaptic integration in rat frontal cortex shaped by network activity. Leger JF, Stern EA, Aertsen A, Heck D, J Neurophysiol 2005 93 281 293 15306631
60. Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition. Haider B, Duque A, Hasenstaub AR, McCormick DA, J Neurosci 2006 26 4535 4545 10.1523/JNEUROSCI.5297-05.2006 16641233
61. N-methyl-D-aspartate receptor mediated component of field potentials evoked in horizontal pathways of rat motor cortex. Hess G, Jacobs KM, Donoghue JP, Neuroscience 1994 61 225 235 10.1016/0306-4522(94)90226-7 7969904
62. Loss of synaptic depression in mammalian anterior cingulate cortex after amputation. Wei F, Li P, Zhuo M, J Neurosci 1999 19 9346 9354 10531439
63. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. Brewer GJ, Torricelli JR, Evege EK, Price PJ, J Neurosci Res 1993 35 567 576 10.1002/jnr.490350513 8377226
64. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, Jiang J, Mei Z, Wang ZG, Guo L, Fei J, Neuropsychopharmacology 2007 32 1531 1539 10.1038/sj.npp. 1301281 17164814
65. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. McClean PL, Parthsarathy V, Faivre E, Holscher C, J Neurosci 2011 31 6587 6594 10.1523/JNEUROSCI.0529-11.2011 21525299